Assessment of Disability Compensation With the C-LEG COMPACT 2 Knee (Ref. 3C60 et 3C60=ST)

NCT ID: NCT02382991

Last Updated: 2019-10-23

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Moderately active amputees may have lost their limb due to diabetes, vascular conditions, trauma, tumour or congenital causes. These amputees currently cannot benefit from having a computerised knee because of the performance criteria associated with being given one. However, these amputees have a very high risk of falling because they use a non microprocessor controlled knee joint (NMPK) and because their physical ability, associated disability and persistent contralateral leg weakness do not allow them to compensate for a balance deficit. These amputees restrict how much they move around and their participation because of their instability and elevated risk of falling.

The objective of the study is to evaluate the effect of the 3C60 knee, a microprocessor-controlled knee joint for external leg prosthesis, on the reduction in the risk of falling after three months in moderately active persons with leg amputation above knee or knee disarticulation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The patient will be evaluated after one month of using his/her usual non micropressor controlled knee joint (NMPK). After fitting of the 3C60, the patient will undergo at least five rehabilitation sessions, adapted to his/her individual needs, so that he/she knows how to use the device and is ready to go along with the planned testing.

After the trial with the 3C60 knee, the patient will again be fitted with his/her non microprocessor controlled knee joint (NMPK) and will be required to undergo one rehabilitation session to regain his/her walking abilities.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amputation of Hip and Thigh, Level Unspecified

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NMPK-3C60

D0 + 30 days: evaluation with the non-microprocessor knee. D1 + 90 days: evaluation with the 3C60 knee.

Group Type OTHER

3C60-NMPK

Intervention Type DEVICE

3 months with 3C60 - 10 days wash out - 1 month with NMPK

3C60-NMPK

D0 + 90 days: evaluation with the 3C60 knee. A period of 10 days of "wash out". D1 + 30 days: evaluation with the non-microprocessor knee.

Group Type OTHER

NMPK-3C60

Intervention Type DEVICE

1 month with NMPK - 3 months with 3C60

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

3C60-NMPK

3 months with 3C60 - 10 days wash out - 1 month with NMPK

Intervention Type DEVICE

NMPK-3C60

1 month with NMPK - 3 months with 3C60

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Mechanical knee joint C-LEG COMPACT 2 KENEVO

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Person with leg amputation above knee or knee disarticulation with stabilized residual limb
* Person who are currently fitted with a prosthesis using a non-microprocessor controlled prosthetic knee
* Person with a high risk of falling, which is defined as a TGUG test score of more than 19 seconds
* Person who moves around within buildings other than one's residence, such as moving around other people's homes, other private buildings, community and private or public buildings and enclosed areas, moving throughout all parts of buildings and enclosed areas, between floors, inside, outside and around buildings, both public and private
* Person who moves around outside the home and other buildings, such as walking and moving around close to or far from one's home and other buildings, without the use of transportation, public or private, such as walking for short or long distances around a town or village, walking or moving down streets in the neighbourhood, town, village or city; moving between cities and further distances, without using transportation
* Person with a daily walking distance greater than 300 m

Exclusion Criteria

* Persons using underarm crutches or walkers
* Persons under 18 years of age
* Persons who weigh more than 125 kg
* Pregnant women
* Persons in an emergency situation
* Persons who cannot personally provide their consent
* Persons who are not available to follow the entire study protocol
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Otto Bock France SNC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gerard Chiesa, Physician

Role: PRINCIPAL_INVESTIGATOR

Institut Robert Merle d'Aubigné - 2 rue du Parc 94460 Valenton - France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sonderkrankenanstalt Zicksee

Sankt Andrä am Zicksee, , Austria

Site Status

CRMPR "Les Herbiers"

Bois-Guillaume, , France

Site Status

Hôpital d'instruction des Armées Percy

Clamart, , France

Site Status

Centre Hospitalier de Cornouaille Concarneau

Concarneau, , France

Site Status

Centre de réadaptation de Coubert

Coubert, , France

Site Status

CHU de Grenoble Hôpital Sud

Échirolles, , France

Site Status

Clinique Chantecler

Marseille, , France

Site Status

Institut Régional de Médecine Physique et de Réadaptation

Nancy, , France

Site Status

Institut National des Invalides

Paris, , France

Site Status

Hôpital Léopold Belan

Paris, , France

Site Status

Pôle Saint-Hélier

Rennes, , France

Site Status

Hôpital privé de l'Est Lyonnais

Saint-Priest, , France

Site Status

Centre l'Adapt Thionis

Thionville, , France

Site Status

Institut Robert Merle d'Aubigné

Valenton, , France

Site Status

Universitätsmedizin Göttingen

Göttingen, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria France Germany

References

Explore related publications, articles, or registry entries linked to this study.

Schoppen T, Boonstra A, Groothoff JW, de Vries J, Goeken LN, Eisma WH. The Timed "up and go" test: reliability and validity in persons with unilateral lower limb amputation. Arch Phys Med Rehabil. 1999 Jul;80(7):825-8. doi: 10.1016/s0003-9993(99)90234-4.

Reference Type BACKGROUND
PMID: 10414769 (View on PubMed)

Dite W, Connor HJ, Curtis HC. Clinical identification of multiple fall risk early after unilateral transtibial amputation. Arch Phys Med Rehabil. 2007 Jan;88(1):109-14. doi: 10.1016/j.apmr.2006.10.015.

Reference Type BACKGROUND
PMID: 17207685 (View on PubMed)

Franchignoni F, Orlandini D, Ferriero G, Moscato TA. Reliability, validity, and responsiveness of the locomotor capabilities index in adults with lower-limb amputation undergoing prosthetic training. Arch Phys Med Rehabil. 2004 May;85(5):743-8. doi: 10.1016/j.apmr.2003.06.010.

Reference Type BACKGROUND
PMID: 15129398 (View on PubMed)

Gauthier-Gagnon C, Grise MC, Potvin D. Enabling factors related to prosthetic use by people with transtibial and transfemoral amputation. Arch Phys Med Rehabil. 1999 Jun;80(6):706-13. doi: 10.1016/s0003-9993(99)90177-6.

Reference Type BACKGROUND
PMID: 10378500 (View on PubMed)

Burnfield JM, Eberly VJ, Gronely JK, Perry J, Yule WJ, Mulroy SJ. Impact of stance phase microprocessor-controlled knee prosthesis on ramp negotiation and community walking function in K2 level transfemoral amputees. Prosthet Orthot Int. 2012 Mar;36(1):95-104. doi: 10.1177/0309364611431611. Epub 2012 Jan 5.

Reference Type BACKGROUND
PMID: 22223685 (View on PubMed)

Gauthier-Gagnon, C, grisé, MCL, Lepage Y. The Locomotor Capabilities Index : Content validity. J rehabil OutcomesMeas 2(4) : 40-46, 1998.

Reference Type BACKGROUND

Gauthier-Gagnon, C, Grisé, MCL, Potvin, L. Predisposing factors related to prosthetic use by people with a transtibial and transfemoral amputation. J Prosthet Orthot 10: 99-109, 1998

Reference Type BACKGROUND

Gauthier-Gagnon C, Grise MC. Prosthetic profile of the amputee questionnaire: validity and reliability. Arch Phys Med Rehabil. 1994 Dec;75(12):1309-14.

Reference Type BACKGROUND
PMID: 7993169 (View on PubMed)

Grise MC, Gauthier-Gagnon C, Martineau GG. Prosthetic profile of people with lower extremity amputation: conception and design of a follow-up questionnaire. Arch Phys Med Rehabil. 1993 Aug;74(8):862-70. doi: 10.1016/0003-9993(93)90014-2.

Reference Type BACKGROUND
PMID: 8347072 (View on PubMed)

Demers L, Weiss-Lambrou R, Ska B. Development of the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST). Assist Technol. 1996;8(1):3-13. doi: 10.1080/10400435.1996.10132268.

Reference Type BACKGROUND
PMID: 10159726 (View on PubMed)

Leplege A, Mesbah M, Marquis P. [Preliminary analysis of the psychometric properties of the French version of an international questionnaire measuring the quality of life: the MOS SF-36 (version 1.1)]. Rev Epidemiol Sante Publique. 1995;43(4):371-9. French.

Reference Type BACKGROUND
PMID: 7667543 (View on PubMed)

Leplège, A. (2001). Introduction, enjeux, définitions. In J. Coste et A. Leplège (Eds.), Mesure de la santé perceptuelle et de la qualité de vie : méthodes et applications (pp 15-36). Paris : Editions Estem

Reference Type BACKGROUND

Ware JE, Snow KK, Kosinski M, Gandek B (1993). Health survey : manual and interpretation guide. Boston, Massachussets : The Health Institute, New England Medical Center, 1993

Reference Type BACKGROUND

Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.

Reference Type BACKGROUND
PMID: 1593914 (View on PubMed)

Loiret I, Paysant J, Martinet N, Andre JM. [Evaluation of amputees]. Ann Readapt Med Phys. 2005 Jul;48(6):307-16. doi: 10.1016/j.annrmp.2005.03.009. Epub 2005 Apr 15. French.

Reference Type BACKGROUND
PMID: 15932782 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014-A00754-43

Identifier Type: REGISTRY

Identifier Source: secondary_id

20PT002-FR-01-0614

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.